Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China
· Delayed Price · Currency is CNY 31.65
+0.55 (1.77%)
Mar 6, 2026, 4:00 PM EST
SHA:688139 Revenue
In the year 2025, Qingdao Haier Biomedical Co.,Ltd had annual revenue of 2.33B CNY with 1.96% growth. Qingdao Haier Biomedical Co.,Ltd had revenue of 567.48M in the quarter ending December 31, 2025, with 13.09% growth.
Revenue
2.33B
Revenue Growth
+1.96%
P/S Ratio
4.20
Revenue / Employee
829.59K
Employees
2,866
Market Cap
9.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.33B | 44.84M | 1.96% |
| Dec 31, 2024 | 2.28B | 2.94M | 0.13% |
| Dec 31, 2023 | 2.28B | -583.15M | -20.36% |
| Dec 31, 2022 | 2.86B | 738.18M | 34.72% |
| Dec 31, 2021 | 2.13B | 723.83M | 51.63% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xiangyu Medical Co.,Ltd | 767.75M |
| Sinocare | 4.71B |
| Shinva Medical Instrument | 9.58B |
| Beijing Wandong Medical Technology | 1.62B |
| Sino Medical Sciences Technology | 504.11M |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.57B |
| Shanghai MicroPort EP MedTech | 464.53M |
| INKON Life Technology | 1.69B |